TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
40,955,908
|
36,709,878
|
30,024,840 |
| Financial expenses |
103,854
|
20,503
|
35,380 |
| Earnings before taxes |
6,386,536
|
4,948,539
|
5,385,096 |
| EBITDA |
8,103,106
|
6,530,541
|
6,854,481 |
| Total assets |
58,482,778
|
49,826,927
|
44,560,567 |
| Current assets |
44,465,440
|
36,851,003
|
31,870,450 |
| Current liabilities |
5,644,376
|
4,671,953
|
4,199,969 |
| Equity capital |
50,296,050
|
43,058,973
|
38,096,082 |
| - share capital |
1,418
|
1,349
|
1,263 |
| Employees (average) |
10,501
|
10,587
|
9,734 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
86.0%
|
86.4%
|
85.5% |
| Turnover per employee |
3,900
|
3,467
|
3,085 |
| Profit as a percentage of turnover |
15.6%
|
13.5%
|
17.9% |
| Return on assets (ROA) |
11.1%
|
10.0%
|
12.2% |
| Current ratio |
787.8%
|
788.8%
|
758.8% |
| Return on equity (ROE) |
12.7%
|
11.5%
|
14.1% |
| Change turnover |
3,584,117
|
4,554,567
|
5,688,247 |
| Change turnover % |
10%
|
14%
|
23% |
| Chg. No. of employees |
-86
|
853
|
1,398 |
| Chg. No. of employees % |
-1%
|
9%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.